Mutabilis' Grant

Mutabilis raised a round of funding on September 20, 2012. Investors include Seventh Framework Programme.

Mutabilis is a biopharmaceutical company specialised in antibacterial drugs. It was founded in 2001 by Xavier Nassif, professor of microbiology at the Necker medical school in Paris and head of Inserm…

Articles about Mutabilis' Grant: